Advertisement

Archives of Gynecology and Obstetrics

, Volume 283, Issue 3, pp 591–596 | Cite as

Focus on haematogenous dissemination of the malignant cystosarcoma phylloides: institutional experience

  • Lukas SchwentnerEmail author
  • Christian Kurzeder
  • Rolf Kreienberg
  • Achim Wöckel
Gynecologic Oncology

Abstract

Introduction

Cystosarcoma phylloides (CSP) is a fibro-epithelial neoplasm of the breast. Not all CSP cases present as malignant tumors; they are therefore classified as benign, malignant, and borderline subtypes according to the WHO classification. The classification is based on several histopathological features of the neoplasm, such as mitosis rate or invasive growth of the tumor. The progression of this disease is mainly influenced by the classification of their degree. In western countries, this tumor entity usually occurs between 50 and 60 years of age. The major problem in the handling of these patients is the high local recurrence rate, whereas haematogenous metastasis is seldom seen. We therefore report three cases of haematogenous spread in a group of eight patients (two borderline and six malignant cases of CSP).

Materials and methods

In this study, we investigated all patients suffering from malignant or borderline CSP, between May 1995 and January 2009, who were under the care of the Department of Gynecology and Obstetrics, University Hospital, Ulm. A written and informed consent was obtained from all patients included in this retrospective study. During this period, eight patients, fulfilling the criteria discussed before, were under the care of the Department of Gynecology and Obstetrics. All therapeutic decisions were taken by the interdisciplinary tumor board of the department (after 1999).

Results

In the retrospective analysis of our study group, we found a high percentage of haematogenous metastasis that was always accompanied with a very poor prognosis in malignant CSP patients. Those patients always died within a short period of time. Two of these patients showed, while they underwent initial surgery, no metastatic suspect lesions and underwent R0 resection; both received a radical mastectomy. One patient already showed lung metastasis while undergoing first line surgery, because she initially declined surgery. We therefore speculate that postoperative adjuvant chemotherapy could lead to a favorable outcome in high risk patients, concerning the development of haematogenous metastasis.

Keywords

Cystosarcoma phylloides Metastasis Haematogenous metastasis 

Notes

Conflict of interest

All authors declare no conflict of interests.

References

  1. 1.
    Müller J (1838) Über den feineren Bau und die Formen krankhafter Geschwulste. Berlin G Reimer 54–57Google Scholar
  2. 2.
    Blichert-Toft M, Hansen JP, Hansen OH, Schiodt T (1975) Clinical course of cystosarcoma phylloides related to histologic appearance. Surg Gynaecol Obstet 140:929–932Google Scholar
  3. 3.
    Azzopardi JG (1979) Problems in breast pathology. Major probl pathol 11:1–466Google Scholar
  4. 4.
    Rowell MD, Perry RR, Hsiu JG, Barranco SC (1993) Phylloides tumors. Am J Surg 165:376–379CrossRefPubMedGoogle Scholar
  5. 5.
    Finocchi L, Covarelli P, Ruli A, Servoli A, Noya G (2008) Bilateral phylloid cystosarcoma of the breast: a case report and review of the literature. Chir Ital 60(6):867–872PubMedGoogle Scholar
  6. 6.
    Vorherr H, Vorherr UF, Kutvirt DM, Key CR (1985) Cystosarkoma phylloides: epidemiology, pathophysiology, pathobiology, diagnosis, therapy and survival. Arch Gynaecol 236:173–181CrossRefGoogle Scholar
  7. 7.
    Tan EY, Tan PH, Yong WS, Wong HB, Ho GH, Yeo AW, Wong CY (2006) Recurrent phylloides tumors of the breast: pathological features and clinical implications. ANZ J Surg 76:476–480CrossRefPubMedGoogle Scholar
  8. 8.
    Rajan P, Cranor M, Rosen P (1998) Cystosarcoma phylloides in adolescent girlsand young women: a study of 45 patients. Am J Surg Pathol 22:64–69CrossRefPubMedGoogle Scholar
  9. 9.
    Cheng SP, Chang YC, Liu TP, Lee JJ, Tzen CY, Liu CL (2006) Phylloides tumor of the breast: the challenge persists. World J Surg 30:1414–1421CrossRefPubMedGoogle Scholar
  10. 10.
    World Health Organization (1982) Histological typing of breast tumors. Tumori 68:181–198Google Scholar
  11. 11.
    Ciatto S, Bonardi R, Cataliotti L, Cardona G (1992) Phylloides tumor of the breast: a multicenter series of 59 cases. Eur J Surg Oncol 18:545–549PubMedGoogle Scholar
  12. 12.
    West TL, Weiland LH, Clagett OT (1971) Cystosarcoma phylloides. Ann Inter Med 173:520–528Google Scholar
  13. 13.
    Reinfuss M, Mitus J, Duda K, Stelmach A, Rys J, Smolak K (1996) The treatment and prognosis of patients with phylloides tumor of the breast. Cancer 77:910–916CrossRefPubMedGoogle Scholar
  14. 14.
    McGregor GI, Knowling MA, Este FA (1994) Sarcoma and cystosarkoma phylloides tumors of the breast: a retrospective analysis of 58 cases. Am J Surg 167:477–480CrossRefPubMedGoogle Scholar
  15. 15.
    Ward RM, Evans HL (1986) Cystosarcoma phylloides. A clinico-pathological study of 26 cases. Cancer 58:2282–2289CrossRefPubMedGoogle Scholar
  16. 16.
    Suzuki-Uematsu S, Shiraishi K, Ito T, Adachi N, Inage Y, Taeda Y, Ueki H, Ohtani H (2009) Malignant phylloides tumor composed almost exclusively of fibrosarcomatous component: a case report and review of malignant phylloides tumors with metastasis. Breast Cancer 17:218–224 (Epub ahead of print)CrossRefPubMedGoogle Scholar
  17. 17.
    Akin M, Irkorucu O, Koksal H, Gonul LL, Gultekin S, Kurukahvecioglu O, Anadol AZ, Tekin E (2010) Phylloides tumor of the breast; a case series. Bratisl Lek Listy 111(5):271–274PubMedGoogle Scholar
  18. 18.
    Hassan M, Abdalla MD, Mona A, Sakr MD (2006) Predictive factors of local recurrence and survival following primary surgical treatment of phylloides tumors of the breast. J Egypt Nat Cancer Inst 18(2):125–133Google Scholar
  19. 19.
    Vorherr H, Vorherr UF, Kutvirt DM, Key CR (1985) Cystosarcoma phylloides: epidemiology, pathohistology, pathobiology, diagnosis, therapy and survival. Arch Gynecol 236:173–181CrossRefPubMedGoogle Scholar
  20. 20.
    Asoglu O, Mustafa M, Blanchard K, Grant CS, Reynolds C, Cha SC, Donohue JH (2004) Risk factors for recurrence and death after primary surgical treatment of malignant phylloides tumors. Ann Surg Oncol 11:123–125CrossRefGoogle Scholar
  21. 21.
    Treves N, Sunderland DA (1951) Cystosarkoma phylloides of the breast: a malignant and benign tumor. A clinico-pathologic study of seventy-seven cases. Cancer 4:1286–1289CrossRefPubMedGoogle Scholar
  22. 22.
    Zurrida S, Bartoli C, Galimberti V, Squicciarini P, Delledone V, Veronesi P (1992) Which therapy for unexpected phylloid tumor of the breast? Eur J Cancer 28:654–656CrossRefPubMedGoogle Scholar
  23. 23.
    Salvadori B, Cusumano F, Del-Bo R, Delledonne V, Grassi M, Rovini D, Saccozzi R, Andreola S, Clemente C (1989) Surgical treatment of phylloides tumors of the breast. Cancer 63:2532–2536CrossRefPubMedGoogle Scholar
  24. 24.
    Di Benedetto G, Sperti V, Grassetti L, Forlini W, Scalise A, Bertani A (2009) Temporary remission of a multirecurrent cystosarcoma phylloides of the breast by using continuous chemotherapy. Plast Reconstr Surg 123(2):72–73CrossRefGoogle Scholar
  25. 25.
    Guerrero MA, Ballard BR, Grau AM (2003) Malignant phylloides tumor of the breast: review of the literature and case report of stromal overgrowth. Surg Oncol 12(1):27–37CrossRefPubMedGoogle Scholar
  26. 26.
    Parker SJ, Harries SA (2001) Phylloides tumor. Postgrad Med J 77:428–435CrossRefPubMedGoogle Scholar
  27. 27.
    Hawkins RE, Schofield JB, Wiltshaw E, Fisher C, McKinna JA (1992) Ifosfamide is an active drug for chemotherapy of metastatic cystosarcoma phyllodes. Cancer 69(9):2271–2275CrossRefPubMedGoogle Scholar
  28. 28.
    Mangi AA, Smith BL, Gadd MA, Tanabe KK, Ott MJ, Souba WW (1999) Surgical management of phylloides tumors. Arch Surg 134:487–492CrossRefPubMedGoogle Scholar
  29. 29.
    Pietruszka M, Barnes L (1978) Cystosarcoma phylloides: A clinico-pathological analysis of 42 cases. Cancer 41:1974–1983CrossRefPubMedGoogle Scholar
  30. 30.
    Cohn-Cedermark G, Rutquist LE, Rosendah I, Silfverswärd C (1991) Prognostic factors in cystosarcoma phylloides. Cancer 68:2017–2022CrossRefPubMedGoogle Scholar
  31. 31.
    Palmer ML, De Risi DC, Pelikan A, Patel J, Nemoto T, Roso D, Dao TL (1990) Therapy options and recurrence potential for cystosarcoma phylloides. Surg Gynecol Obstet 179(3):173–176Google Scholar
  32. 32.
    Faraci RP, Schour L (1974) Radical treatment of recurrent cystosarcoma phylloides. Ann Surg 180:796–798CrossRefPubMedGoogle Scholar
  33. 33.
    Burton GV, Hart LL, Leight GS, Iglehart JD, McCarty KS, Cox EB (1989) Cystosarcoma phyllodes. Effective therapy with cisplatin and etoposide chemotherapy. Cancer 63(11):2088–2092CrossRefPubMedGoogle Scholar
  34. 34.
    Allen R, Nixon D, York M, Coleman J (1985) Successful chemotherapy for cystosarcoma phyllodes in a young woman. Arch Intern Med 145(6):1127–1128CrossRefPubMedGoogle Scholar
  35. 35.
    Grenier J, Delbaldo C, Zelek L, Piedbois P (2010) Phylloides tumors and breast sarcomas: a review. Bull Cancer 97:1197–1207 (Epub ahead of print)PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Lukas Schwentner
    • 1
    Email author
  • Christian Kurzeder
    • 1
  • Rolf Kreienberg
    • 1
  • Achim Wöckel
    • 1
  1. 1.Department of Gynecology and ObstetricsUniversity Hospital UlmUlmGermany

Personalised recommendations